Results 31 to 40 of about 7,838 (234)
What is the value of faster acting prandial insulin? Focus on ultra rapid lispro
Diabetes, obesity and metabolism, 2022 Rapid‐acting insulins (RAIs) have been instrumental in the management of diabetes because of their improved postprandial glucose (PPG) control compared with regular human insulin.
T. Heise +5 more
semanticscholar +1 more source
Diabetes, obesity and metabolism, 2022 To evaluate the efficacy and safety of ultra‐rapid lispro (URLi) versus lispro in a paediatric population with type 1 diabetes (T1D) in a Phase 3, treat‐to‐target study.
R. Wadwa +5 more
semanticscholar +1 more source
Glucocorticoid-Induced Hyperglycaemia in Hospital: The Insulin Dose Matters Most. [PDF]
Diabetes Obes MetabABSTRACT Prescription of glucocorticoids in hospital is a common cause of new onset hyperglycaemia, which is associated with increased mortality and morbidity. However, to date studies have not defined optimal treatment of hyperglycaemia associated with glucocorticoids and this is reflected in clinical guidelines.
Burt MG +3 more
europepmc +2 more sources
Costo-efectividad del tratamiento con insulina para el control de diabetes mellitus tipo 2 en México
Horizonte Sanitario, 2022 Objetivo: Identificar la intervención más costo-efectiva para el tratamiento de la diabetes mellitus tipo 2, en el primer nivel de atención, cuando el paciente requiere del uso de algún tipo de insulina, con base en estudios clínicos previos ...
Pablo López-Esteves +4 more
doaj +1 more source
Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes : systematic review and economic evaluation [PDF]
, 2010 Based on the totality of evidence, using observational studies to supplement the limited data from randomised trials against best MDI, CSII provides some advantages over MDI in T1DM for both children and adults.
P Royle +13 more
core +1 more source
Exenatide versus Insulin Lispro Added to Basal Insulin in a Subgroup of Korean Patients with Type 2 Diabetes Mellitus [PDF]
Diabetes & Metabolism Journal, 2017 BackgroundThe prevalence of type 2 diabetes mellitus (T2DM) and obesity is increasing in Korea. Clinical studies in patients with T2DM have shown that combining the glucagon-like peptide-1 receptor agonist exenatide twice daily with basal insulin is an ...
Kun-Ho Yoon, Elise Hardy, Jenny Han
doaj +1 more source
Journal of Diabetes Science and Technology, 2022 Background: It has been shown that insulin acceleration by itself might not be sufficient to see clear improvements in glycemic metrics, and insulin therapy may need to be adjusted to fully leverage the extra safety margin provided by faster ...
P. Colmegna +4 more
semanticscholar +1 more source
Flexibility in insulin prescription
Indian Journal of Endocrinology and Metabolism, 2016 This communication explores the concept of flexibility, a propos insulin preparations and insulin regimes used in the management of type 2 diabetes.
Sanjay Kalra +2 more
doaj +1 more source
Diabetes Therapy, 2022 Ultra-rapid lispro (URLi) is a new prandial insulin lispro formulation. In the PRONTO-T2D study, URLi, in a basal-bolus regimen with glargine or degludec, was non-inferior to lispro (Humalog®) for HbA1c reduction and superior for postprandial glucose ...
Qianyi Zhang +2 more
semanticscholar +1 more source
Indian Journal of Endocrinology and Metabolism, 2015 Premix insulins are commonly used insulin preparations, which are available in varying ratios of different molecules. These drugs contain one short- or rapid-acting, and one intermediate- or long-acting insulin. High-mix insulins are mixtures of insulins
Sanjay Kalra +2 more
doaj +1 more source